A Study to Evaluate the Safety and Efficacy of Elagolix for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women

A Study to Evaluate the Safety and Efficacy of Elagolix for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women

Condition:   Uterine Fibroids
Interventions:   Drug: Elagolix;   Drug: Placebo
Sponsor:   AbbVie
Not yet recruiting
ClinicalTrials.gov: Womens_Health | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

March 25, 2019 / by / in
Comments